Phase 1 BKV Infection Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

EBV InfectionCMV InfectionBKV Infection

LucasBio27 enrolled1 locationNCT07670468

Recruiting

Phase 1Phase 2

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

TuberculosisEBV InfectionAdenovirus Infection+4 more

Shenzhen Geno-Immune Medical Institute100 enrolled1 locationNCT03159364